1. Home
  2. OSK vs NUVL Comparison

OSK vs NUVL Comparison

Compare OSK & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oshkosh Corporation

OSK

Oshkosh Corporation

HOLD

Current Price

$152.96

Market Cap

9.8B

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$101.34

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSK
NUVL
Founded
1917
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
8.3B
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
OSK
NUVL
Price
$152.96
$101.34
Analyst Decision
Buy
Strong Buy
Analyst Count
14
16
Target Price
$166.79
$134.75
AVG Volume (30 Days)
463.4K
472.5K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
1.55%
N/A
EPS Growth
N/A
N/A
EPS
1.14
N/A
Revenue
$7,705,500,000.00
N/A
Revenue This Year
$5.94
N/A
Revenue Next Year
$7.19
$1,239.49
P/E Ratio
$137.37
N/A
Revenue Growth
12.83
N/A
52 Week Low
$90.74
$69.85
52 Week High
$180.49
$113.02

Technical Indicators

Market Signals
Indicator
OSK
NUVL
Relative Strength Index (RSI) 52.45 47.50
Support Level $137.24 $97.94
Resistance Level $158.57 $107.49
Average True Range (ATR) 5.20 3.67
MACD 0.66 -0.41
Stochastic Oscillator 57.24 33.33

Price Performance

Historical Comparison
OSK
NUVL

About OSK Oshkosh Corporation

Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (45% of revenue), Vocational (35%), and Transport (20%) on 2025 revenue of $10.4 billion.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: